In this Healthed lecture, endocrinologist, Prof Peter Ebeling AO explains that IV iron infusion has been shown to induce hypophosphataemia in a substantial proportion of patients. In many it is transient, but in a small number it can be profound. The effect seems more pronounced with some preparations and less with others - up to 47% of patients following ferric carboxymaltose (FCM) infusions for iron deficiency. However, it is rarely seen following ferric derisomaltose (FDI). If iron infusion-induced hypophosphataemia is severe and long-lasting, it can lead to osteomalacia and bone pain. Recipients of repeated IV iron infusions seem particularly vulnerable to bone effects. Prof Ebeling AO will describe his clinical experience with this phenomenon and the clinical implications for GP. 

<p>In this Healthed lecture, endocrinologist, Prof Peter Ebeling AO explains that IV iron infusion has been shown to induce hypophosphataemia in a substantial proportion of patients. In many it is transient, but in a small number it can be profound. The effect seems more pronounced with some preparations and less with others - up to 47% of patients following ferric carboxymaltose (FCM) infusions for iron deficiency. However, it is rarely seen following ferric derisomaltose (FDI). If iron infusion-induced hypophosphataemia is severe and long-lasting, it can lead to osteomalacia and bone pain. Recipients of repeated IV iron infusions seem particularly vulnerable to bone effects. Prof Ebeling AO will describe his clinical experience with this phenomenon and the clinical implications for GP. </p>

Healthed's medical education channel features the latest high quality clinical interviews and lectures from leading experts in their field, offering health professionals a convenient new way to boost their knowledge.

Advertisement